Biosimilars: Starting a patient on biologic therapy
Update: 2022-12-12
Description
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.
In episode 1 of 4, we’ll discuss:
• How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic?
• What are some of the common questions that patients ask and how do you address them?
• Do you set goals of therapy with your patients and what are they?
This series is supported by independent medical education grants from Amgen and Pfizer.
To collect CME credit for listening, visit agau.gastro.org.
In episode 1 of 4, we’ll discuss:
• How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic?
• What are some of the common questions that patients ask and how do you address them?
• Do you set goals of therapy with your patients and what are they?
This series is supported by independent medical education grants from Amgen and Pfizer.
To collect CME credit for listening, visit agau.gastro.org.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
